Clinical Trial Update: Cetylpyridium Chloride (CPC) Based Chewing Gum and Gingivitis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating cetylpyridinium chloride–based chewing gum for gingivitis and plaque; completed with results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gingivitis
• Periodontal Diseases
• Plaque Dental

Drugs mentioned

• cetylpyridinium chloride based chewing gum (cetylpyridinium chloride)

Snippet

Sponsor: The University of Texas Health Science Center, Houston | Conditions: Gingivitis, Plaque, Dental | Phase 4 | Status: COMPLETED | Results posted: 2021-02-08